| 1 |
33509057 | PAX2 promoter methylation and AIB1 overexpression promote tamoxifen resistance in breast carcinoma patients. | 2022 Mar |
1 |
| 2 |
34086424 | The rate of estrogen receptor-conversion associated with tumor progression in estrogen receptor-positive breast cancer patients following adjuvant Tamoxifen administration. | 2022 Jan |
9 |
| 3 |
34196110 | Chinese breast cancer patients with CYP2D6*10 mutant genotypes have a better prognosis with toremifene than with tamoxifen. | 2022 Apr |
3 |
| 4 |
34331393 | Knockdown of ER-α36 expression inhibits glioma proliferation, invasion and epithelial-to-mesenchymal transition. | 2022 Feb |
1 |
| 5 |
34463889 | Successful treatment of a case of hormone receptor-positive metastatic extramammary Paget disease with tamoxifen. | 2022 Feb |
1 |
| 6 |
34763600 | Selective estrogen receptor degraders (SERDs) and covalent antagonists (SERCAs): a patent review (2015-present). | 2022 Feb |
1 |
| 7 |
34821461 | Low concentrations of 17β-estradiol exacerbate tamoxifen resistance in breast cancer treatment through membrane estrogen receptor-mediated signaling pathways. | 2022 Mar |
1 |
| 8 |
34845001 | Network Analysis Identifies Regulators of Basal-Like Breast Cancer Reprogramming and Endocrine Therapy Vulnerability. | 2022 Jan 15 |
1 |
| 9 |
34896436 | p21 activated kinase-1 and tamoxifen - A deadly nexus impacting breast cancer outcomes. | 2022 Jan |
1 |
| 10 |
34923243 | Structure-based design and synthesis of conformationally constrained derivatives of methyl-piperidinopyrazole (MPP) with estrogen receptor (ER) antagonist activity. | 2022 Feb |
2 |
| 11 |
35000145 | Targeting CDK7 reverses tamoxifen resistance through regulating stemness in ER+ breast cancer. | 2022 Apr |
2 |
| 12 |
35020071 | BCL3 expression is strongly associated with the occurrence of breast cancer relapse under tamoxifen treatment in a retrospective cohort study. | 2022 Mar |
2 |
| 13 |
35054486 | Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. | 2022 Jan 10 |
4 |
| 14 |
35057779 | Arrabidaea chica chloroform extract modulates estrogen and androgen receptors on luminal breast cancer cells. | 2022 Jan 20 |
4 |
| 15 |
35079352 | microRNA-221 and tamoxifen resistance in luminal-subtype breast cancer patients: A case-control study. | 2022 Jan |
1 |
| 16 |
35081258 | ERα/β/DMP1 axis promotes trans-differentiation of chondrocytes to bone cells through GSK-3β/β-catenin pathway. | 2022 Jun |
2 |
| 17 |
35110502 | RSK-Mediated Non-canonical Activation of EphA2 by Tamoxifen. | 2022 |
3 |
| 18 |
35118192 | Narciclasine targets STAT3 via distinct mechanisms in tamoxifen-resistant breast cancer cells. | 2022 Mar 17 |
3 |
| 19 |
35148282 | Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin α6β1 drives endocrine resistance in breast cancer cells. | 2022 Feb 11 |
1 |
| 20 |
35154350 | Paeoniflorin Enhances the Sensitivity of ER-Positive Breast Cancer Cells to Tamoxifen through Promoting Sirtuin 4. | 2022 |
1 |
| 21 |
35182276 | Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients. | 2022 Feb 19 |
1 |
| 22 |
35205279 | Role of the Mediator Complex and MicroRNAs in Breast Cancer Etiology. | 2022 Jan 26 |
1 |
| 23 |
35205702 | Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer. | 2022 Feb 14 |
1 |
| 24 |
35221731 | Antileishmanial Activity of Tamoxifen by Targeting Sphingolipid Metabolism: A Review. | 2022 |
1 |
| 25 |
35256592 | Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma. | 2022 Mar 7 |
4 |
| 26 |
35263089 | Diethylhexyl Phthalate and Bisphenol A Promote Vincristine and Tamoxifen Resistance in Vitro. | 2022 Mar 21 |
1 |
| 27 |
35264224 | Selective pressure of endocrine therapy activates the integrated stress response through NFκB signaling in a subpopulation of ER positive breast cancer cells. | 2022 Mar 9 |
1 |
| 28 |
35267559 | Targeting Ribosome Biogenesis to Combat Tamoxifen Resistance in ER+ve Breast Cancer. | 2022 Feb 28 |
1 |
| 29 |
35273179 | Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models. | 2022 Mar 10 |
2 |
| 30 |
35337112 | Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines. | 2022 Mar 5 |
2 |
| 31 |
35379454 | 16α-18F-fluoro-17β-Fluoroestradiol (FES): Clinical Applications for Patients With Breast Cancer. | 2022 Apr 1 |
2 |
| 32 |
35392925 | TRIM3 facilitates estrogen signaling and modulates breast cancer cell progression. | 2022 Apr 7 |
1 |
| 33 |
35410558 | Acute pancreatitis secondary to tamoxifen-associated hypertriglyceridemia: A clinical update. | 2022 Apr 12 |
1 |
| 34 |
35431927 | Tamoxifen Twists Again: On and Off-Targets in Macrophages and Infections. | 2022 |
2 |
| 35 |
35445730 | EGFR inhibition reverses epithelial‑mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells. | 2022 Jun |
2 |
| 36 |
35447603 | FE65 defines the efficacy of tamoxifen treatment via osteopontin expression in estrogen receptor-positive breast cancer. | 2022 Jun |
4 |
| 37 |
35449318 | DLGAP1-AS2 promotes estrogen receptor signalling and confers tamoxifen resistance in breast cancer. | 2022 May |
1 |
| 38 |
35471238 | Down-regulation of ABCB1 by Collateral Sensitivity Drugs Reverses Multidrug Resistance and Up-regulates Enolase I. | 2022 Apr 26 |
1 |
| 39 |
35482141 | Functional network analysis of p85 and PI3K as potential gene targets and mechanism of oleanolic acid in overcoming breast cancer resistance to tamoxifen. | 2022 Apr 28 |
1 |
| 40 |
35583138 | Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast Cancer. | 2022 May 2 |
4 |
| 41 |
35594462 | Estrogen for the Treatment and Prevention of Breast Cancer: A Tale of 2 Karnofsky Lectures. | 2022 May-Jun 01 |
1 |
| 42 |
35616371 | Bazedoxifene, a Postmenopausal Drug, Acts as an Antimalarial and Inhibits Hemozoin Formation. | 2022 May 26 |
1 |
| 43 |
32472997 | The Antitumor Effects of Icaritin Against Breast Cancer is Related to Estrogen Receptors. | 2021 |
1 |
| 44 |
32865695 | miR-484 suppresses endocrine therapy-resistant cells by inhibiting KLF4-induced cancer stem cells in estrogen receptor-positive cancers. | 2021 Jan |
1 |
| 45 |
32931953 | Role of cholesterol metabolism in the anticancer pharmacology of selective estrogen receptor modulators. | 2021 Aug |
1 |
| 46 |
33086249 | Tamoxifen prevention of meningioma and its proposal for the treatment of meningioma. Revisiting old data in the light of recent epidemiological observations. | 2021 Sep 1 |
3 |
| 47 |
33252186 | Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen. | 2021 Apr |
1 |
| 48 |
33262438 | Nitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cells. | 2021 Mar |
1 |
| 49 |
33275817 | Targeted inhibition of ERα signaling and PIP5K1α/Akt pathways in castration-resistant prostate cancer. | 2021 Apr |
1 |
| 50 |
33320718 | Recent advances in the personalized treatment of estrogen receptor-positive breast cancer with tamoxifen: a focus on pharmacogenomics. | 2021 Mar |
1 |